Latest Breaking News On - Barry kappel - Page 1 : comparemela.com

Marshfield man wins award for work removing invasive species

MARSHFIELD, Wis. - A Marshfield man won an award for his work removing invasive species from Marshfield s parks and trails and restoring its ecological diversity by planting and nurturing service

United statesNecedah national wildlife refugeCarol berg kappelDan umhoeferBarry kappelWisconsin invasive species council actionInvasive species councilInvasive species actionNecedah national wildlife

Sapience Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

/PRNewswire/ Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address.

Amy conradBarry kappelSapience therapeutics incSapience therapeuticsAnnual needham virtual healthcare conferenceStabilized peptides engineered against regulationInvestor contact

Sapience Therapeutics Presents New ST101 Phase 2 Clinical Data In GBM At The 2023 Society For Neuro-Oncology (SNO) Annual Meeting

Sapience Therapeutics Presents New ST101 Phase 2 Clinical Data In GBM At The 2023 Society For Neuro-Oncology (SNO) Annual Meeting
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesFabiom iwamotoAmy conradBarry kappelSapience therapeutics incDivision of neuroPrnewswire sapience therapeutics incSociety for neuroEuropean commissionPresbyterian columbia university medical centerDisease control rateNewly diagnosedAnnual meetingPresentation detailsColumbia university medical

Sapience Therapeutics Presents ST101 Clinical Data and ST316 Preclinical Data at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Sapience Therapeutics Presents ST101 Clinical Data and ST316 Preclinical Data at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Juniper pointUnited statesBarry kappelAmy conradInternational conference on molecularImmunostimulatory propertiesSapience therapeutics incPrnewswire sapience therapeutics incEuropean commissionMolecular targetsCancer therapeuticsPresentation detailsBiological activityPeptide antagonistRecurrent glioblastomaResults from

Sapience Therapeutics Awarded $2 Million Grant to Evaluate the Therapeutic Potential of ST316, a First-in-Class β-catenin Antagonist

Sapience Therapeutics Awarded $2 Million Grant to Evaluate the Therapeutic Potential of ST316, a First-in-Class β-catenin Antagonist
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJim rotoloAmy conradBarry kappelDrug administrationNational cancer instituteHead of research sapience therapeuticsSapience therapeutics incSmall business innovation researchAmerican association for cancer researchNational institutes of healthSapience therapeuticsNational institutesTranslational pharmacologyAmerican associationCancer research